title: Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.
authors.affiliation: Department of Internal Medicine, University of Arizona Medical Center, Tucson, Arizona, USA.
authors.forename: Seongseok
authors.initials: S
authors.lastname: Yun
authors.forename: Faiz
authors.initials: F
authors.lastname: Anwer
authors.forename: Nicole D
authors.initials: ND
authors.lastname: Vincelette
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D000069439:Dasatinib; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib